{{Rsnum
|rsid=10503256
|Gene=CSMD1
|Chromosome=8
|position=4356657
|Orientation=plus
|GMAF=0.4178
|Gene_s=CSMD1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.2 | 40.7 | 45.1
| HCB | 11.7 | 44.5 | 43.8
| JPT | 8.8 | 56.6 | 34.5
| YRI | 45.6 | 44.2 | 10.2
| ASW | 42.1 | 38.6 | 19.3
| CHB | 11.7 | 44.5 | 43.8
| CHD | 15.6 | 44.0 | 40.4
| GIH | 28.0 | 48.0 | 24.0
| LWK | 50.0 | 38.2 | 11.8
| MEX | 1.7 | 37.9 | 60.3
| MKK | 26.9 | 53.8 | 19.2
| TSI | 14.7 | 36.3 | 49.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=9E-7
|OR=1.1000
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}